UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q
ý |
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
or |
|
o |
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the Quarter Ended September 27, 2003 |
Commission File No. 1-12620
PLAYTEX PRODUCTS, INC.
(Exact name of registrant as specified in its charter)
Delaware (State or other jurisdiction of incorporation or organization) |
51-0312772 (I.R.S. Employer Identification No.) |
|
300 Nyala Farms Road Westport, Connecticut 06880 (Address of principal executive offices) |
||
Telephone number: (203) 341-4000 (Registrant's telephone number, including area code) |
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports) and (2) has been subject to such filing requirements for the past 90 days.
Yes ý No o
Indicate by check mark whether the registrant is an accelerated filer (as defined in Rule 12b-2 of the Act).
Yes ý No o
At November 7, 2003 61,215,856 shares of Playtex Products, Inc. common stock, par value $.01 per share, were outstanding.
|
|
PAGE |
||
---|---|---|---|---|
PART IFINANCIAL INFORMATION | ||||
Item 1. |
Consolidated Financial Statements |
3 - 17 |
||
Item 2. |
Management's Discussion and Analysis of Financial Condition and Results of Operations |
18 - 29 |
||
Item 3. |
Quantitative and Qualitative Disclosure about Market Risk |
30 |
||
Item 4. |
Controls and Procedures |
30 |
||
PART IIOTHER INFORMATION |
||||
Item 1. |
Legal Proceedings |
31 |
||
Item 6. |
Exhibits and Reports on Form 8-K: |
|||
(a) Exhibits |
31 |
|||
(b) Reports on Form 8-K |
31 |
|||
Signatures |
32 |
2
PLAYTEX PRODUCTS, INC.
CONSOLIDATED BALANCE SHEETS
(In thousands, except share data)
|
September 27, 2003 |
December 28, 2002 |
|||||||
---|---|---|---|---|---|---|---|---|---|
|
(Unaudited) |
|
|||||||
ASSETS | |||||||||
Current assets: | |||||||||
Cash | $ | 41,391 | $ | 31,605 | |||||
Receivables, less allowance for doubtful accounts | 33,569 | 27,735 | |||||||
Retained interest in receivables | 54,108 | 59,774 | |||||||
Inventories | 67,386 | 85,160 | |||||||
Due from related party | 80,017 | 80,017 | |||||||
Deferred income taxes | 6,906 | 8,130 | |||||||
Income taxes receivable | 3,715 | | |||||||
Other current assets | 6,484 | 7,782 | |||||||
Total current assets | 293,576 | 300,203 | |||||||
Net property, plant and equipment |
124,102 |
121,199 |
|||||||
Intangible assets, net: | |||||||||
Goodwill | 494,307 | 494,307 | |||||||
Trademarks, patents and other | 138,497 | 139,174 | |||||||
Deferred financing costs | 13,673 | 13,592 | |||||||
Other noncurrent assets | 8,887 | 9,712 | |||||||
Total assets | $ | 1,073,042 | $ | 1,078,187 | |||||
LIABILITIES AND STOCKHOLDERS' EQUITY |
|||||||||
Current liabilities: | |||||||||
Accounts payable | $ | 34,253 | $ | 47,088 | |||||
Accrued expenses | 61,845 | 54,217 | |||||||
Due to related party | 78,386 | 78,386 | |||||||
Income taxes payable | 8,023 | 1,086 | |||||||
Current maturities of long-term debt | 2,250 | 4,500 | |||||||
Total current liabilities | 184,757 | 185,277 | |||||||
Long-term debt |
791,000 |
823,250 |
|||||||
Other noncurrent liabilities | 15,707 | 14,526 | |||||||
Deferred income taxes | 54,062 | 49,601 | |||||||
Total liabilities | 1,045,526 | 1,072,654 | |||||||
Stockholders' equity: | |||||||||
Common stock, $0.01 par value, authorized 100,000,000 shares, issued 61,215,856 shares at September 27, 2003 and December 28, 2002 | 612 | 612 | |||||||
Additional paid-in capital | 526,233 | 526,233 | |||||||
Retained earnings (deficit) | (497,580 | ) | (516,771 | ) | |||||
Accumulated other comprehensive earnings (loss) | (1,749 | ) | (4,541 | ) | |||||
Total stockholders' equity | 27,516 | 5,533 | |||||||
Total liabilities and stockholders' equity | $ | 1,073,042 | $ | 1,078,187 | |||||
See accompanying notes to unaudited consolidated financial statements.
3
PLAYTEX PRODUCTS, INC.
CONSOLIDATED STATEMENTS OF EARNINGS
(Unaudited, in thousands, except per share data)
|
Three Months Ended |
||||||||
---|---|---|---|---|---|---|---|---|---|
|
September 27, 2003 |
September 28, 2002 |
|||||||
Net sales | $ | 150,051 | $ | 161,567 | |||||
Cost of sales | 72,047 | 76,072 | |||||||
Gross profit | 78,004 | 85,495 | |||||||
Operating expenses: |
|||||||||
Selling, general and administrative | 58,161 | 56,494 | |||||||
Amortization of intangibles | 226 | 241 | |||||||
Total operating expenses | 58,387 | 56,735 | |||||||
Operating earnings |
19,617 |
28,760 |
|||||||
Interest expense, net of interest income, including related party interest expense of $3,037 for both periods presented, net of related party interest income of $3,001 for both periods presented |
14,226 |
14,186 |
|||||||
Other expense | 448 | 536 | |||||||
Earnings before income taxes | 4,943 | 14,038 | |||||||
Income taxes | 1,809 | 5,152 | |||||||
Net earnings | $ | 3,134 | $ | 8,886 | |||||
Earnings per share: | |||||||||
Basic | $ | 0.05 | $ | 0.15 | |||||
Diluted | $ | 0.05 | $ | 0.14 | |||||
Weighted average shares outstanding: | |||||||||
Basic | 61,216 | 61,211 | |||||||
Diluted | 61,216 | 61,496 | |||||||
See accompanying notes to unaudited consolidated financial statements.
4
PLAYTEX PRODUCTS, INC.
CONSOLIDATED STATEMENTS OF EARNINGS
(Unaudited, in thousands, except per share data)
|
Nine Months Ended |
|||||||||
---|---|---|---|---|---|---|---|---|---|---|
|
September 27, 2003 |
September 28, 2002 |
||||||||
Net sales | $ | 511,013 | $ | 559,870 | ||||||
Cost of sales | 243,016 | 249,494 | ||||||||
Gross profit | 267,997 | 310,376 | ||||||||
Operating expenses: |
||||||||||
Selling, general and administrative | 194,633 | 185,377 | ||||||||
Restructuring and asset impairment | | 7,599 | ||||||||
Amortization of intangibles | 677 | 692 | ||||||||
Total operating expenses | 195,310 | 193,668 | ||||||||
Operating earnings | 72,687 | 116,708 | ||||||||
Interest expense, net of interest income, including related party interest expense of $9,112 for both periods presented, net of related party interest income of $9,002 for both periods presented |
41,060 |
45,540 |
||||||||
Expenses related to retirement of debt | | 5,882 | ||||||||
Other expenses | 1,473 | 2,107 | ||||||||
Earnings before income taxes and change in accounting principle | 30,154 | 63,179 | ||||||||
Income taxes |
10,963 |
9,015 |
||||||||
Earnings before change in accounting principle | 19,191 | 54,164 | ||||||||
Cumulative effect of change in accounting principle, net of $7,141 tax benefit | | (12,423 | ) | |||||||
Net earnings | $ | 19,191 | $ | 41,741 | ||||||
Earnings per shareBasic: | ||||||||||
Earnings before cumulative effect of change in accounting principle | $ | 0.31 | $ | 0.88 | ||||||
Cumulative effect of change in accounting principle | | (0.20 | ) | |||||||
Earnings per shareBasic | $ | 0.31 | $ | 0.68 | ||||||
Earnings per shareDiluted: | ||||||||||
Earnings before cumulative effect of change in accounting principle | $ | 0.31 | $ | 0.86 | ||||||
Cumulative effect of change in accounting principle | | (0.19 | ) | |||||||
Earnings per shareDiluted | $ | 0.31 | $ | 0.67 | ||||||
Weighted average shares outstanding: | ||||||||||
Basic | 61,216 | 61,126 | ||||||||
Diluted | 61,230 | 64,173 | ||||||||
See accompanying notes to unaudited consolidated financial statements.
5
PLAYTEX PRODUCTS, INC.
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY
AND ACCUMULATED OTHER COMPREHENSIVE EARNINGS (LOSS)
(Unaudited, in thousands)
|
Common Shares Outstanding |
Common Stock |
Additional Paid-In Capital |
Retained Earnings (Deficit) |
Accumulated Other Comprehensive Earnings (Loss) |
Total |
||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Balance, December 28, 2002 | 61,216 | $ | 612 | $ | 526,233 | $ | (516,771 | ) | $ | (4,541 | ) | $ | 5,533 | |||||
Net earnings |
|
|
|
19,191 |
|
19,191 |
||||||||||||
Foreign currency translation adjustment |
|
|
|
|
2,792 |
2,792 |
||||||||||||
Comprehensive earnings |
21,983 |
|||||||||||||||||
Balance, September 27, 2003 | 61,216 | $ | 612 | $ | 526,233 | $ | (497,580 | ) | $ | (1,749 | ) | $ | 27,516 | |||||
See accompanying notes to unaudited consolidated financial statements.
6
PLAYTEX PRODUCTS, INC.
CONSOLIDATED STATEMENTS OF CASH FLOWS
(Unaudited, in thousands)
|
Nine Months Ended |
|||||||||
---|---|---|---|---|---|---|---|---|---|---|
|
September 27, 2003 |
September 28, 2002 |
||||||||
Cash flows from operations: | ||||||||||
Net earnings | $ | 19,191 | $ | 41,741 | ||||||
Adjustments to reconcile net earnings to net cash flows from operations: | ||||||||||
Cumulative effect of change in accounting principle, net of tax benefit | | 12,423 | ||||||||
Asset impairment charge | | 4,222 | ||||||||
Expenses related to retirement of debt | | 5,882 | ||||||||
Depreciation | 10,566 | 10,521 | ||||||||
Amortization of deferred financing costs | 1,543 | 1,617 | ||||||||
Amortization of intangibles | 677 | 692 | ||||||||
Deferred income taxes | 5,745 | (4,402 | ) | |||||||
Other, net | 5,209 | 1,727 | ||||||||
Net decrease (increase) in working capital accounts | 16,750 | (15,881 | ) | |||||||
Net cash flows from operations | 59,681 | 58,542 | ||||||||
Cash flows used for investing activities: |
||||||||||
Purchases of property, plant and equipment | (13,771 | ) | (10,581 | ) | ||||||
Intangible assets acquired, net | | (515 | ) | |||||||
Net cash flows used for investing activities | (13,771 | ) | (11,096 | ) | ||||||
Cash flows (used for) provided by financing activities: |
||||||||||
Net borrowings under credit facilities | | (17,000 | ) | |||||||
Long-term debt borrowings | | 450,000 | ||||||||
Long-term debt repayments | (4,500 | ) | (474,050 | ) | ||||||
Repayment of convertible notes | (30,000 | ) | | |||||||
Payment of financing costs | (1,624 | ) | (3,522 | ) | ||||||
Issuance of shares of common stock | | 1,603 | ||||||||
Net cash flows used for financing activities | (36,124 | ) | (42,969 | ) | ||||||
Increase in cash |
9,786 |
4,477 |
||||||||
Cash at beginning of period | 31,605 | 34,006 | ||||||||
Cash at end of period | $ | 41,391 | $ | 38,483 | ||||||
Supplemental disclosures of cash flow information |
||||||||||
Cash paid during the periods for: | ||||||||||
Interest | $ | 31,481 | $ | 34,296 | ||||||
Income taxes, net of refunds | $ | 1,997 | $ | 5,997 |
See accompanying notes to unaudited consolidated financial statements.
7
PLAYTEX PRODUCTS, INC.
PART IFINANCIAL INFORMATION
NOTES TO THE UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
1. Consolidated Financial Statements
The interim consolidated financial statements, which are a part of our Quarterly Report on Form 10-Q, are unaudited. In preparing our financial statements, we make certain adjustments (consisting of normal recurring adjustments) considered necessary in our opinion for a fair presentation of our financial position and results of operations. The results of the three and nine month periods ended September 27, 2003 are not necessarily indicative of the results that you may expect for the full year.
We presume you have access to the audited consolidated financial statements contained in our Annual Report on Form 10-K for the year ended December 28, 2002. As a result, we have not included footnote disclosures that would substantially duplicate the disclosures contained in the Form 10-K. We file our annual, quarterly, current reports, proxy statements, and other documents with the Securities and Exchange Commission (the "SEC") under the Securities Act of 1933 and the Securities Exchange Act of 1934. You may read and copy any materials that we file with the SEC at the SEC's Public Reference Room at 450 Fifth Street, NW, Washington, DC 20549. The SEC also maintains an internet website that contains our filed reports at www.sec.gov. In addition, we make our filings with the SEC available at the Investor Relations section of our website www.playtexproductsinc.com. You can call our Investor Relations Department at (203) 341-4017 or via email at invrel@playtex.com to request a copy of any of our reports filed with the SEC.
2. Stock-Based Compensation
We account for stock-based compensation in accordance with Statement of Financial Accounting Standards ("SFAS") No. 123, "Accounting for Stock-Based Compensation," as amended by SFAS No. 148, "Accounting for Stock-Based CompensationTransition and Disclosure". As permitted by SFAS No. 123 and SFAS No. 148, we follow the intrinsic value approach of Accounting Principles Board Opinion No. 25 ("APB No. 25"), and Financial Accounting Standards Board ("FASB") Interpretation No. 44, "Accounting for Certain Transactions Involving Stock-Based Compensation, an Interpretation of APB No. 25" issued for determining compensation expense related to the issuance of stock options. Accordingly, we do not recognize compensation expense related to our stock option program. Had we recognized compensation expense under the fair value approach permitted by SFAS No. 123, which measures and expenses the fair value of each stock option on the date of grant, our earnings and earnings per share would have been reduced to the pro forma amounts listed below (unaudited, in thousands, except per share data):
|
Three Months Ended |
Nine Months Ended |
|||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
September 27, 2003 |
September 28, 2002 |
September 27, 2003 |
September 28, 2002 |
|||||||||||
Net earnings: | |||||||||||||||
As reported | $ | 3,134 | $ | 8,886 | $ | 19,191 | $ | 41,741 | |||||||
Deduct: Total stock-based employee compensation expense determined under the fair value method for stock option awards | (586 | ) | (944 | ) | (2,150 | ) | (1,487 | ) | |||||||
Pro formaBasic | $ | 2,548 | $ | 7,942 | $ | 17,041 | $ | 40,254 | |||||||
Add: Interest on Convertible Notes, net of tax | | | | 1,419 | |||||||||||
Pro formaDiluted | $ | 2,548 | $ | 7,942 | $ | 17,041 | $ | 41,673 | |||||||
Earnings per share: | |||||||||||||||
As reported | |||||||||||||||
Basic | $ | 0.05 | $ | 0.15 | $ | 0.31 | $ | 0.68 | |||||||
Diluted | $ | 0.05 | $ | 0.14 | $ | 0.31 | $ | 0.67 | |||||||
Pro forma | |||||||||||||||
Basic | $ | 0.04 | $ | 0.13 | $ | 0.28 | $ | 0.66 | |||||||
Diluted | $ | 0.04 | $ | 0.13 | $ | 0.28 | $ | 0.65 | |||||||
Weighted average common shares and common equivalent shares outstanding: |
|||||||||||||||
Basic | 61,216 | 61,211 | 61,216 | 61,126 | |||||||||||
Diluted | 61,216 | 61,496 | 61,230 | 64,173 |
8
The fair value of each stock option grant was estimated on the date of grant using the Black-Scholes option-pricing model, which uses a number of assumptions to estimate the value of stock option grants. Assumptions used in the Black-Scholes option-pricing model include: risk-free interest rates, dividend yield if applicable, expected option life and the volatility of the underlying stock price.
3. Impact of Adopting New Accounting Pronouncements
Effective December 30, 2001, the beginning of our 2002 fiscal year, we adopted the provisions of SFAS No. 142, "Goodwill and Other Intangible Assets," which changed our accounting for goodwill and other intangible assets with indefinite lives from an amortization method to an impairment only approach. In accordance with the requirements of SFAS No. 142, we tested the goodwill attributable to each of our reporting units for impairment as of December 30, 2001 and determined that none of our goodwill was impaired. Also, in accordance with the requirements of SFAS No. 142, we tested each of our trademarks for impairment by comparing the fair value of each trademark to its carrying value at December 30, 2001. Fair value was estimated using the relief from royalty method (a discounted cash flow methodology). Based on these impairment tests, we recorded a charge, reported as a cumulative effect of change in accounting principle, of $19.6 million ($12.4 million net of tax benefits) for the nine months ended September 28, 2002. This charge reduced the trademark carrying value of certain non-core brands, primarily Chubs and Diaparene, to their estimated fair value. We are required to test our goodwill and trademarks for impairment, based on the methodologies as outlined in SFAS No. 142, on an annual basis and more frequently if events or circumstances indicate a likelihood of impairment. We performed the required annual goodwill and intangibles impairment testing during the second quarter of 2003 and no reduction in goodwill or trademark balances were required.
In April 2002, the FASB issued SFAS No. 145, "Rescission of FASB Statements No. 4, 44, and 64, Amendment of FASB Statement No. 13, and Technical Corrections." We adopted this statement effective December 29, 2002, the first day of fiscal 2003. This statement updates, clarifies and simplifies existing accounting pronouncements and requires that gains and losses on extinguishments of debt be classified as income or loss from continuing operations rather than as extraordinary items as previously required under the old accounting rules. Any gain or loss on extinguishment of debt previously classified as an extraordinary item in prior periods that does not meet the criteria of APB No. 30 for such classification has been reclassified to conform to the provisions of SFAS No. 145. We recorded a pre-tax extraordinary loss during the second quarter ended June 29, 2002 of $5.9 million associated with the write-off of unamortized deferred financing costs relating to the retirement of our Term A Loan and Term B Loan (see Note 8 in our unaudited consolidated financial statements). In accordance with SFAS No. 145, we have reclassified the $5.9 million pre-tax loss from extraordinary loss to earnings from continuing operations. In addition, we reduced income tax expense by $2.2 million to reclassify the tax benefit of this transaction in accordance with the new accounting standard.
Effective June 29, 2003, we adopted SFAS No. 149, "Amendment of Statement 133 on Derivative Instruments and Hedging Activities." This statement amends and clarifies financial accounting and reporting for derivatives and for hedging activities under SFAS No. 133, "Accounting for Derivative Instruments and Hedging Activities." This standard had no impact on our consolidated financial statements.
In May 2003, the FASB issued SFAS No. 150, "Accounting for Certain Financial Instruments with Characteristics of both Liabilities and Equity." This standard requires that certain financial instruments embodying an obligation to transfer assets to issue equity securities be classified as liabilities. It is effective for financial instruments entered into or modified after May 31, 2003, and otherwise is effective July 1, 2003. This standard has no impact on our consolidated financial statements.
In January 2003, the FASB issued Interpretation No. 46 ("FIN 46"), "Consolidation of Variable Interest Entities." FIN 46 requires a company to consolidate a variable interest entity (VIE), as defined, when the company will absorb a majority of the VIE's expected losses, receive a majority of the VIE's expected residual returns, or both. FIN 46 also requires consolidation of existing, non-controlled affiliates if the VIE is unable to finance its operations without investor
9
support, or where the other investors do not have exposure to the significant risks and rewards of ownership. FIN 46 applies immediately to a VIE created or acquired after January 31, 2003. For a VIE created before February 1, 2003, FIN 46 applies in the first fiscal year or interim period beginning after December 15, 2003. This interpretation has no impact on our consolidated financial statements.
4. Restructuring and Impairment Costs
In the first quarter of 2002, we recorded a pre-tax restructuring and asset impairment charge of $7.6 million as a result of our decision to close our Watervliet, New York plastic molding facility. The write-off of assets associated with the closure of the facility was approximately $4.2 million and severance and other exit costs related to the termination of employees were estimated at $3.4 million. As of September 27, 2003, we spent $3.2 million related to severance and other exit costs since we announced our intent to close the facility in the first quarter of 2002. The Watervliet facility manufactured component parts primarily for our infant feeding category and employed approximately 160 people at the time of the announcement.
5. Impact of Tax Regulations
In the first quarter of 2002, the U.S. Treasury issued new regulations that replaced the loss disallowance rules applicable to the sale of stock of a subsidiary member of a consolidated tax group. These regulations permitted us to utilize a previously disallowed $135.1 million tax capital loss that resulted from the sale of Playtex Beauty Care, Inc. during fiscal 1999. We can utilize the tax capital loss associated with the sale of Playtex Beauty Care, Inc. to offset capital gains during the statutory five-year carryforward period. We anticipate utilizing $40.0 million of the capital loss to offset a capital gain, in fiscal 2003, related to the retirement of our related party notes, which come due on December 15, 2003. Accordingly, we recorded a tax benefit of $14.3 million in the first quarter of 2002. The remaining capital loss carryover will expire on December 25, 2004, if not utilized. The remaining tax benefit associated with the capital loss carryforward has been reduced by a valuation allowance, as we do not currently expect to realize it. The tax benefit related to the new regulations, recorded in the first quarter of 2002, does not impact our effective tax rate during fiscal 2003. We expect our effective tax rate during fiscal 2003 to be between 36% and 37% of earnings before income taxes.
6. Accumulated Other Comprehensive Earnings (Loss)
The accumulated balances for each classification of other comprehensive earnings (loss) are as follows (unaudited, in thousands):
|
Foreign Currency Translation Adjustment |
Minimum Pension Liability Adjustment |
Accumulated Other Comprehensive Earnings (Loss) |
||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Balance, December 28, 2002 | $ | (3,778 | ) | $ | (763 | ) | $ | (4,541 | ) | ||
Change in period | 2,792 | | 2,792 | ||||||||
Balance, September 27, 2003 | $ | (986 | ) | $ | (763 | ) | $ | (1,749 | ) | ||
10
7. Balance Sheet Components
The components of certain balance sheet accounts are as follows (in thousands):
|
September 27, 2003 |
December 28, 2002 |
|||||||
---|---|---|---|---|---|---|---|---|---|
|
(Unaudited) |
|
|||||||
Cash | $ | 30,693 | $ | 23,105 | |||||
Cashlock box(a) | 10,698 | 8,500 | |||||||
Net | $ | 41,391 | $ | 31,605 | |||||
Receivables | $ | 34,240 | $ | 28,707 | |||||
Less allowance for doubtful accounts | (671 | ) | (972 | ) | |||||
Net | $ | 33,569 | $ | 27,735 | |||||
Inventories: | |||||||||
Raw materials | $ | 14,232 | $ | 18,780 | |||||
Work in process | 1,348 | 2,125 | |||||||
Finished goods | 51,806 | 64,255 | |||||||
Total | $ | 67,386 | $ | 85,160 | |||||
Net property, plant and equipment: | |||||||||
Land | $ | 2,376 | $ | 2,376 | |||||
Buildings | 41,202 | 39,694 | |||||||
Machinery and equipment | 193,406 | 183,200 | |||||||
236,984 | 225,270 | ||||||||
Less accumulated depreciation | (112,882 | ) | (104,071 | ) | |||||
Net | $ | 124,102 | $ | 121,199 | |||||
Accrued expenses: | |||||||||
Advertising and sales promotion | $ | 12,393 | $ | 16,665 | |||||
Employee compensation and benefits | 7,409 | 15,769 | |||||||
Interest | 15,900 | 7,864 | |||||||
Insurance | 1,721 | 1,501 | |||||||
Other | 24,422 | 12,418 | |||||||
Total | $ | 61,845 | $ | 54,217 | |||||
11
Long-term debt consists of the following (in thousands):
|
September 27, 2003 |
December 28, 2002 |
|||||||
---|---|---|---|---|---|---|---|---|---|
|
(Unaudited) |
|
|||||||
Variable rate indebtedness: | |||||||||
Term C Loan | $ | 443,250 | $ | 447,750 | |||||
Fixed rate indebtedness: | |||||||||
93/8% Senior Subordinated Notes due 2011 | 350,000 | 350,000 | |||||||
6% Convertible Subordinated Notes due 2004 | | 30,000 | |||||||
793,250 | 827,750 | ||||||||
Less current maturities | (2,250 | ) | (4,500 | ) | |||||
Total long-term debt | $ | 791,000 | $ | 823,250 | |||||
On May 22, 2001, we completed a refinancing of our senior indebtedness (the "Refinancing Transaction"). As part of the Refinancing Transaction we issued:
In addition, we entered into a receivables purchase agreement (the "Receivables Facility") with a third party through a wholly-owned consolidated special purpose bankruptcy remote subsidiary of ours, Playtex A/R LLC. The net proceeds from the Refinancing Transaction and the Receivables Facility were used to pay-off all of our then outstanding indebtedness, except for the 6% Convertible Subordinated Notes (the "6% Convertible Notes").
On May 29, 2002, we amended our Credit Facility and issued a new $450.0 million Term C Loan and, together with $21.8 million of cash, we repaid in full our outstanding obligations under our Term A Loan and Term B Loan, which collectively totaled $471.8 million.
On June 26, 2003, we amended our Credit Facility. This amendment provided for revised and more stringent financial covenants and increased the interest rate margin on our Term C Loan and Revolving Credit Facility. Under the revised terms, pricing for London Inter-Bank Offer Rate ("LIBOR") based loans was increased and a Senior Debt Leverage Ratio, as defined in the amended credit agreement, was added. Additionally, pricing for LIBOR-based loans increased by 125 basis points to LIBOR plus 350 basis points for the Term C Loan and 100 basis points to LIBOR plus 400 basis points for the Revolving Credit Facility. Based on our current outstanding indebtedness, the revised pricing would increase our interest expense by approximately $5.5 million on an annualized basis. The amendment requires that we affirm that we are in compliance with our Senior Debt Leverage Ratio prior to initiating any borrowing requests. Compliance is based on the most recent quarterly compliance certificate filed with the banks, as adjusted to reflect proposed new Senior Debt balances. Based upon our most recent quarterly compliance certificate, our maximum Senior Debt borrowing may not exceed $465.0 million. At September 27, 2003, our Senior Debt was $443.3 million. Additionally, as a result of the amendment to the senior indebtedness, we paid amendment fees of approximately $1.6 million. These costs were deferred and are being amortized over the remaining term of our Credit Facility.
12
Fixed Rate Indebtedness
Our fixed rate indebtedness at September 27, 2003 of $350.0 million consists solely of our 93/8% Notes. We pay interest on the 93/8% Notes semi-annually on June 1 and December 1 of each year. At any time prior to June 1, 2004, we may redeem up to 35% of the principal amount of the 93/8% Notes with the proceeds of one or more equity offerings at a redemption price of 109.375% of the principal amount, plus accrued and unpaid interest to the redemption date. We do not have the option to redeem the 93/8% Notes from June 1, 2004 through May 31, 2006. At our option, we may redeem the notes on or after June 1, 2006 at the redemption prices (expressed as a percentage of principal amount) listed below plus accrued and unpaid interest to the redemption date.
Year |
Percentage |
|
---|---|---|
2006 | 104.688 | |
2007 | 103.125 | |
2008 | 101.563 | |
2009 and thereafter | 100.000 |
On April 24, 2003, we redeemed $20.0 million principal amount of our 6% Convertible Notes. On September 19, 2003, we redeemed the remaining $10.0 million principal amount of our 6% Convertible Notes.
Variable Rate Indebtedness
Our variable rate indebtedness of $443.3 million at September 27, 2003 is comprised entirely of our Term C Loan. The rates of interest we pay under the Term C Loan and Revolving Credit Facility vary over time depending on short-term interest rates. We also pay fees on our Revolving Credit Facility commitments, which may vary depending on our credit rating. Loans made under the Revolving Credit Facility mature on May 22, 2007 and our final principal payment on the Term C Loan is due May 31, 2009. Scheduled principal payments on the Term C Loan are made semi-annually and amount to: $4.5 million per year in fiscal years 2004 through 2007, $213.8 million in 2008, and $211.5 million in 2009. We repaid $4.5 million of the Term C Loan during the nine month period ended September 27, 2003.
We periodically use financial instruments, such as derivatives, to manage the impact of interest rate changes on our variable rate debt. At September 27, 2003, we were not a party to any derivative or other type of financial instrument that hedged the impact of interest rate changes on our variable rate debt. Based on our interest rate exposure at September 27, 2003, a 1% increase in interest rates would result in an estimated $4.4 million of additional interest expense on an annualized basis.
The rates of interest we pay on our variable rate debt are, at our option, a function of various alternative short term borrowing rates, such as the Prime Rate or LIBOR.
13
The provisions of the credit agreement for our Credit Facility require us to meet certain financial covenants and ratios and include limitations and restrictions, including:
|
indebtedness and liens, |
|
certain dividends and other distributions, |
|||
| major acquisitions or mergers, | | the application of excess cash flow, and | |||
| capital expenditures and asset sales, | | prepayment and modification of all | |||
indebtedness or equity capitalization. |
The 93/8% Notes also contain certain restrictions and requirements. Under the terms of each of these agreements, payment of cash dividends on our common stock is restricted. Certain of our wholly owned subsidiaries are guarantors of the 93/8% Notes.
At September 27, 2003, our required principal repayments (excluding balances outstanding on our Revolving Credit Facility and amounts due to related party) were:
|
$4.5 million in 2004, |
|
$4.5 million in 2007, |
|||
| $4.5 million in 2005, | | $213.8 million in 2008, and | |||
| $4.5 million in 2006, | | $561.5 million thereafter. |
In the event that we have excess cash flow, as defined in our Credit Facility, we are, within 90 days of each year-end, required to make mandatory debt repayments on the Term C Loan equal to the amount of the excess cash flow, as defined. At the end of fiscal 2002, we determined that we had excess cash flow as defined in our Credit Facility and we deposited, in March of 2003, $19.1 million into the excess cash flow account. This $19.1 million, along with $0.9 million of additional cash, was used to redeem $20.0 million of our 6% Convertible Notes on April 24, 2003, as allowed under our Credit Agreement.
9. Receivables Facility
On May 22, 2001, we entered into the Receivables Facility through a wholly-owned, special purpose bankruptcy remote subsidiary of ours, Playtex A/R LLC. Through the Receivables Facility, we sell on a continuous basis to Playtex A/R LLC substantially all of our domestic customers' trade invoices that we generate. Playtex A/R LLC sells to a third-party commercial paper conduit (the "Conduit") an undivided fractional ownership interest in these trade accounts receivable. The Conduit issues short-term commercial paper to finance the purchase of the undivided fractional interest in the receivables. The total funding available to us on a revolving basis under the Receivables Facility is up to $100.0 million, depending primarily on: the amount of receivables generated by us and sold to Playtex A/R LLC, the rate of collection on those receivables, and other characteristics of the receivables pool which affects their eligibility. Our Retained Interest in Receivables represents our subordinated fractional undivided interest in receivables sold to Playtex A/R LLC and the net unamortized deferred financing costs incurred by Playtex A/R LLC.
Commitments under the Receivables Facility have terms of 180 days, which may be renewed at the option of the Conduit prior to termination. In May 2003, the Receivables Facility was extended through November 2003. We have initiated the process to renew this facility prior to the November 2003 termination date.
We have agreed to continue servicing the sold receivables at market rates; accordingly, no servicing asset or liability has been recorded. Playtex A/R LLC shares credit risk with the Conduit as the undivided fractional interest in the receivables are sold without recourse. We believe, however, that Playtex A/R LLC has most of the credit risk associated with customers that do not pay, as the Conduit has preferential treatment with regard to cash settlement procedures and other conditions that limit their credit exposure. Our retained interest in receivables will be negatively impacted if Playtex A/R LLC writes-off any receivable balances as uncollectible. We believe the Receivables Facility is beneficial to us as: (1) we convert trade receivables to cash faster, and (2) although we sell our invoices to Playtex A/R LLC at a discount and pay fees to the Conduit, these expenses are lower than our borrowing costs under the Credit Facility.
14
At September 27, 2003, Playtex A/R LLC had approximately $73.1 million of receivables, of which $19.0 million of undivided fractional interest therein was sold to the Conduit. Since the beginning of fiscal 2003, we sold in aggregate approximately $463.4 million of accounts receivable to Playtex A/R LLC and we have received from Playtex A/R LLC approximately $466.9 million of cash.
We sell receivables at a discount, which is included in Other Expenses in the Consolidated Statements of Earnings. This discount, which was $0.4 million for the third quarter of 2003 and $1.4 million for the nine month period ended September 27, 2003, reflects the estimated fees required by the Conduit to purchase a fractional undivided interest in the receivables. The fees are based on the payment characteristics of the receivables, most notably their average life, interest rates in the commercial paper market and historical credit losses. Also included in Other Expenses is the impact of the amortization of deferred financing costs incurred by Playtex A/R LLC to establish the Receivables Facility.
We account for the sale of accounts receivable to Playtex A/R LLC and related transactions with the Conduit in accordance with SFAS No. 140, "Accounting for Transfers and Servicing of Financial Assets and Extinguishments of Liabilities." At the time the receivables are sold, the balances are removed from our balance sheet. Playtex A/R LLC pays fees on the value of the undivided interest of the receivables sold to the Conduit equal to the 30 day LIBOR rate, which is reset weekly. In addition, under the terms of the May 2003 renewal of the Receivables Facility, Playtex A/R LLC pays a 0.50% per annum fee on the utilized portion of the Receivables Facility and a 0.75% per annum liquidity fee on the entire committed amount of the Receivables Facility. Because of the short-term nature, generally less than 60 days, of our trade accounts receivable sold to Playtex A/R LLC and the historically low credit risk associated with these receivables, the carrying value of our Retained Interest in Receivables approximates the fair value.
The Receivables Facility may be terminated prior to its term in the event of:
|
nonpayment of fees or |
|
bankruptcy events, |
|||
other amounts when due, | | material judgments, | ||||
| violation of covenants, | | defaults under the Receivables Facility, | |||
| failure of any representation or | | a servicing default, and | |||
warranty to be true in all material respects when made, |
| a downgrade in the Senior Secured Credit Facility to less than B- by S&P and less than B3 by Moody's. |
10. Business Segments
We are organized in three divisions:
Our Personal Products Division includes Infant Care and Feminine Care products sold in the United States primarily to mass merchandisers, grocery and drug classes of trade. The Infant Care product category includes the following brands:
| Playtex disposable nurser system, | | Baby Magic infant toiletries, | |||
cups and reusable hard bottles, | | Mr. Bubble children's bubble bath, | ||||
| Wet Ones hand and face towelettes, | | Baby Magic baby wipes, and | |||
| Diaper Genie diaper disposal system, | | Binky pacifiers. |
The Feminine Care product category includes a wide range of plastic and cardboard applicator tampons, as well as complementary products, marketed under such brand names as:
Tampons | Complementary Products | |||||
| Playtex Gentle Glide, | | Playtex Personal Cleansing Cloths | |||
| Playtex Portables, | for use in feminine hygiene, and | ||||
| Playtex Slimfits, | | Playtex Heat Therapy patch to | |||
| Playtex Silk Glide, | alleviate discomfort associated | ||||
with menstrual pain. |
15
Our Consumer Products Division includes a number of leading and well-recognized brands sold in the United States primarily to mass merchandisers, grocery and drug classes of trade. The Consumer Products Division includes the following brands:
| Banana Boat Sun Care products, | | Binaca breath spray and drops, | |||
| Woolite rug and upholstery cleaning products, | | Tussy deodorant, | |||
| Playtex Gloves, | | Dentax oral care products, and | |||
| Ogilvie at-home permanents, | | Tek toothbrushes. |
Our International/Corporate Sales Division includes:
| Sales to specialty classes of trade in | | export sales, | |||
the United States including: | | results from our Canadian and | ||||
warehouse clubs, military, convenience | Australian subsidiaries, | |||||
stores, specialty stores, and | | sales in Puerto Rico, and | ||||
telemarketing, | | sales of private label tampons. |
The International/Corporate Sales Division sells the same products as are available to our U.S. customers.
The results of our divisions for the three and nine months ended September 27, 2003 and September 28, 2002 are as follows (dollars in thousands):
|
Three Months Ended |
|||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
September 27, 2003 |
September 28, 2002 |
||||||||||||
|
Net Sales |
Product Contrib. |
Net Sales |
Product Contrib. |
||||||||||
Personal Products | $ | 98,495 | $ | 42,400 | $ | 106,148 | $ | 49,436 | ||||||
Consumer Products | 18,981 | 3,326 | 20,639 | 3,038 | ||||||||||
International/Corporate Sales | 32,575 | 14,359 | 34,780 | 16,537 | ||||||||||
Unallocated Charges | | (166 | ) | | (207 | ) | ||||||||
Total Consolidated | $ | 150,051 | 59,919 | $ | 161,567 | 68,804 | ||||||||
Reconciliation to operating earnings: | ||||||||||||||
Selling, distribution, research and administrative | 40,076 | 39,803 | ||||||||||||
Amortization of intangibles | 226 | 241 | ||||||||||||
Operating earnings | $ | 19,617 | $ | 28,760 | ||||||||||
|
Nine Months Ended |
|||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
September 27, 2003 |
September 28, 2002 |
||||||||||||
|
Net Sales |
Product Contrib. |
Net Sales |
Product Contrib. |
||||||||||
Personal Products | $ | 284,033 | $ | 112,056 | $ | 324,652 | $ | 156,758 | ||||||
Consumer Products | 130,795 | 40,242 | 129,778 | 38,698 | ||||||||||
International/Corporate Sales | 96,185 | 42,103 | 105,440 | 49,256 | ||||||||||
Unallocated Charges | | (366 | ) | | (457 | ) | ||||||||
Total Consolidated | $ | 511,013 | 194,035 | $ | 559,870 | 244,255 | ||||||||
Reconciliation to operating earnings: | ||||||||||||||
Selling, distribution, research and administrative | 120,671 | 119,256 | ||||||||||||
Restructuring and asset impairment | | 7,599 | ||||||||||||
Amortization of intangibles | 677 | 692 | ||||||||||||
Operating earnings | $ | 72,687 | $ | 116,708 | ||||||||||
16
11. Earnings Per Share
The following table explains how our basic and diluted Earnings Per Share ("EPS") were calculated for the three and nine months ended September 27, 2003 and September 28, 2002 (unaudited, in thousands, except per share amounts):
|
Three Months Ended |
Nine Months Ended |
|||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
September 27, 2003 |
September 28, 2002 |
September 27, 2003 |
September 28, 2002 |
|||||||||||
Numerator: | |||||||||||||||
Earnings before change in accounting principleas reported | $ | 3,134 | $ | 8,886 | $ | 19,191 | $ | 54,164 | |||||||
Effect of Dilutive Securities: | |||||||||||||||
Adjustment for interest on Convertible Notes |
| | | 1,419 | |||||||||||
Earnings before change in accounting principle adjusted for assumed dilutive conversions | 3,134 | 8,886 | 19,191 | 55,583 | |||||||||||
Cumulative effect of change in accounting principle | | | | (12,423 | ) | ||||||||||
Net earningsas adjusted | $ | 3,134 | $ | 8,886 | $ | 19,191 | $ | 43,160 | |||||||
Denominator: |
|||||||||||||||
Weighted average shares outstandingBasic | 61,216 | 61,211 | 61,216 | 61,126 | |||||||||||
Effect of Dilutive Securities: | |||||||||||||||
Adjustment for dilutive effect of employee stock options | | 285 | 14 | 436 | |||||||||||
Adjustment for dilutive effect of Convertible Notes | | | | 2,611 | |||||||||||
Weighted average shares outstandingDiluted | 61,216 | 61,496 | 61,230 | 64,173 | |||||||||||
Earnings per shareBasic: |
|||||||||||||||
Earnings before change in accounting principle | $ | 0.05 | $ | 0.15 | $ | 0.31 | $ | 0.88 | |||||||
Cumulative effect of change in accounting principle | | | | (0.20 | ) | ||||||||||
Earnings per share | $ | 0.05 | $ | 0.15 | $ | 0.31 | $ | 0.68 | |||||||
Earnings per shareDiluted: |
|||||||||||||||
Earnings before change in accounting principle | $ | 0.05 | $ | 0.14 | $ | 0.31 | $ | 0.86 | |||||||
Cumulative effect of change in accounting principle | | | | (0.19 | ) | ||||||||||
Earnings per share | $ | 0.05 | $ | 0.14 | $ | 0.31 | $ | 0.67 | |||||||
Basic EPS excludes all potentially dilutive securities. Basic EPS is computed by dividing net earnings by the weighted average number of common shares outstanding for the period. Diluted EPS includes all potentially dilutive securities. Dilutive securities include stock options granted to our employees and shares that may be exchanged for the 6% Convertible Notes, if determined to be dilutive. Diluted EPS is computed by dividing net earnings, adjusted by the if-converted method for convertible securities, by the weighted average number of common shares outstanding for the period plus the number of additional common shares that would have been outstanding if the dilutive securities were issued. In the event the dilutive securities are anti-dilutive on earnings before cumulative effect of change in accounting principle (have the affect of increasing EPS), the impact of the dilutive securities is not included in the computation.
12. Contingent Liabilities
In our opinion, there are no claims, commitments, guarantees or litigation pending to which we or any of our subsidiaries is a party which would have a material adverse effect on the consolidated financial position, results of operations or cash flows of the Company.
17
PLAYTEX PRODUCTS, INC.
PART IFINANCIAL INFORMATION
MANAGEMENT'S DISCUSSION AND ANALYSIS
Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations.
The following discussion and analysis of our financial condition and results of operations should be read in conjunction with:
Cautionary Statement for Purposes of the "Safe Harbor" Provisions of the Private Securities Litigation Reform Act of 1995
This document includes forward-looking statements. We have based these forward-looking statements on our current expectations and projections about future results. When we use words in this document such as "anticipates," "intends," "plans," "believes," "estimates," "expects," and similar expressions we do so to identify forward-looking statements. Our actual results may differ materially from those anticipated in these forward-looking statements. These forward-looking statements are affected by risks, uncertainties, and assumptions that we make, including, among other things, the Risk Factors that are listed in Item 1. of our Annual Report on Form 10-K for the year ended December 28, 2002, and:
| price and product changes, | | impact of weather conditions, especially | |||
| promotional activity by competitors, | on Sun Care product sales, | ||||
| the loss or bankruptcy of a significant customer, | | our level of debt and related covenant restrictions, | |||
| capacity limitations, | | interest rate fluctuations, | |||
| the difficulties of integrating acquisitions, | | future cash flows, | |||
| raw material and manufacturing costs, | | dependence on key employees, and | |||
| adverse publicity and product liability claims, | | highly competitive nature of consumer products business. |
You should keep in mind that any forward-looking statement made by us in this document, or elsewhere, speaks only as of the date on which we make it. New risks and uncertainties come up from time to time, and it's impossible for us to predict these events or how they may affect us. In light of these risks and uncertainties, you should keep in mind that any forward-looking statements made in this report or elsewhere might not occur. In addition, the preparation of financial statements in accordance with generally accepted accounting principles requires us to make estimates and assumptions. These estimates and assumptions affect:
Actual results may vary from our estimates and assumptions. These estimates and assumptions are based on historical results, assumptions that we make as well as assumptions by third parties. The level of reserves for Sun Care product returns, bad debts and advertising and promotional costs are three areas of which you should be aware (see Management's Discussion and AnalysisCritical Accounting Policies). As part of our customary review and reconciliation process, we periodically record adjustments to our accounting estimates.
18
Trademarks
We have proprietary rights to a number of trademarks important to our business, such as: Active Sport, Baby Magic, Banana Boat, Beyond, Binaca, Blasters, Big Sipster, Cool Colorz, CoolStraw, Diaper Genie, Dentax, Drop-Ins, Fast Blast, Gentle Glide, Get On The Boat, Gripster, HandSaver, Heat Therapy, Heavy Traffic, Insulator, LipPops, Most Like Mother, Mr. Bubble, Natural Action, NaturalShape, Ogilvie, Oxy Deep, Power Shot, Precisely Right, QuickStraw, Quik Blok, Safe'N Sure, Silk Glide, SipEase, Sparklin' Sipster, Slimfits, Sooth-A-Caine, Suntanicals, Tub Mate, Tek, Tussy, VentAire, VitaSkin, and Wet Ones. We also own a royalty free license in perpetuity to the Playtex and Living trademarks, and to the Woolite trademark for rug and upholstery cleaning products in the United States and Canada.
Items Affecting Comparability
Our results for the third quarter of 2003 are for the 13-week period ended September 27, 2003 and our results for the third quarter of 2002 are for the 13-week period ended September 28, 2002. All references to market share and market share data are for comparable 13-week periods and represent our percentage of the total U.S. dollar volume of products purchased by consumers in the applicable category (dollar market share or retail consumption). This information is provided to us from the ACNielsen Company and is subject to revisions. This market share data does not include scanner/consumption data from certain retailers including Wal-Mart Stores, Inc., as they do not provide this information to third parties.
In April 2002, the Financial Accounting Standards Board ("FASB") issued Statement of Financial Accounting Standards ("SFAS") No. 145, "Rescission of FASB Statements No. 4, 44, and 64, Amendment of FASB Statement No. 13, and Technical Corrections" ("SFAS No. 145"). This statement updated, clarified and simplified existing accounting pronouncements and became effective for us starting in fiscal 2003. In most instances, SFAS No. 145 required gains and losses on extinguishments of debt to be classified as income or loss from continuing operations rather than as extraordinary items as previously required under the old accounting rules. Starting in 2003, any gain or loss on extinguishment of debt previously classified as an extraordinary item in prior periods presented that does not meet the criteria of APB No. 30 for such classification was reclassified to conform to the provisions of SFAS No. 145. In accordance with SFAS No. 145, we have reclassified the May 2002 $5.9 million pre-tax extraordinary loss to earnings from continuing operations. In addition, we reduced income tax expense by $2.2 million to reclassify the tax benefit of this transaction in accordance with the new accounting standard.
We also adopted, on December 30, 2001, SFAS No. 142, "Goodwill and Other Intangible Assets." As a result of the adoption of SFAS No. 142, we ceased the amortization of: (a) all of our remaining goodwill balance and (b) trademarks that were determined to have indefinite lives. In connection with the new requirements set forth in SFAS No. 142, we performed impairment tests on our indefinite-lived intangible assets based on a fair value concept. As a result of this testing, we recorded an after tax impairment in trademarks for certain non-core businesses of $12.4 million as a cumulative effect of change in accounting principle in the first quarter of 2002 (see Note 3 in our unaudited consolidated financial statements).
On March 7, 2002, the U.S. Treasury issued new regulations that replaced the loss disallowance rules applicable to the sale of stock of a subsidiary member of a consolidated tax group. These regulations permit us to utilize a previously disallowed $135.1 million tax capital loss that resulted from the sale of Playtex Beauty Care, Inc., during fiscal 1999. We anticipate utilizing $40.0 million of the capital loss to offset a capital gain, in fiscal 2003, related to the retirement of our related party notes, which come due on December 15, 2003. Accordingly, we recorded a tax benefit of $14.3 million in the first quarter of 2002 (see Note 5 in our unaudited consolidated financial statements).
19
Results of Operations
Three Months Ended September 27, 2003 Compared To
Three Months Ended September 28, 2002
Consolidated Net SalesOur consolidated net sales decreased $11.5 million, or 7%, to $150.1 million in the third quarter of 2003.
Personal Products DivisionNet sales decreased $7.7 million, or 7%, to $98.5 million in the third quarter of 2003.
Net sales of Infant Care products decreased $0.7 million, or 1%, to $53.2 million in the third quarter of 2003. This decrease was due primarily to lower net sales for our non-core baby wipes business. Overall market shares for the third quarter versus year ago were stable to slightly improved in Infant Feeding, Diaper Genie, Wet Ones and Mr. Bubble. Market share for Baby Magic Toiletries lagged the year ago quarter due to promotional activity in a highly competitive category. We believe our core Infant Care categories are highly competitive and we will continue to defend our market share positions. We have a number of new product offerings scheduled to launch in the next several months. We are expanding our hard bottle offering with VentAire NaturalShape, an expansion of our category leading reusable bottle developed for consumers who switch between breast-feeding and bottle-feeding. This bottle includes a patented nipple that, we believe, aids in this transition. We are also introducing a one-step breast-feeding storage kit, which allows consumers to go from breast pump to storage to feeding using our Drop-In sac technology. Other new products include the Sparklin' Sipster spill-proof cup, a revamped look for our base spill-proof cup line and the addition of a Baby Magic Calming Milk shampoo to our Baby Toiletries line.
Net sales of Feminine Care products decreased $7.0 million, or 13%, to $45.3 million in the third quarter of 2003. Our dollar market share in Tampons decreased 3.6 percentage points in the third quarter of 2003, to 26.7%, from 30.3% in the third quarter of 2002. Our retail consumption of Tampons declined 10.8% while the category grew 1.3%. The decrease in net sales was due, in part, to a more heavily promoted time period during the third quarter of 2002. At this time last year, we were aggressively promoting as a defensive strategy against a competitive product launch aimed directly at our plastic applicator tampon. Shipment trends in our plastic applicator tampon continue to improve as the impact of the competitive launch stabilizes. Plastic tampon shipments lagged consumption during the first half of the year due to inventory build resulting from heavy promotional activity. While this trend continued during the third quarter, the gap between shipments and consumption has narrowed. Tampon market share has also stabilized, since the launch of the competitive product, at approximately 27%. The quarterly net sales comparison was also impacted by heavier shipments of Heat Therapy in the third quarter of 2002 to support its initial launch. In the third quarter of 2003, we announced the launch of a new flushable tampon, Playtex Beyond. Playtex Beyond is scheduled for shipment in January 2004. This tampon will be targeted to women that want the convenience and flushability of a cardboard product with the comfort of a plastic tampon. The flushable segment remains a significant portion of the tampon market. We believe this new product will provide us with an opportunity to capture a greater share of the flushable market.
Consumer Products DivisionNet sales decreased $1.7 million, or 8%, to $19.0 million in the third quarter of 2003.
Net sales of Sun Care products increased $0.3 million in the third quarter of 2003. The sun care business is highly seasonal and the third quarter is typically the lowest quarterly period for net sales. For the third quarter, our dollar market share of the Sun Care category decreased 0.9 percentage points to 22.1%, from 23.0% in the third quarter of 2002. We believe we are well positioned for the upcoming Sun Care season with an array of new products, including Surf, a long lasting, waterproof sunscreen, a new SPF 50 product for children, the highest offered in this segment, and expanded offerings in our Suntanicals line.
20
Net sales of Household Products/Personal Grooming decreased $2.0 million, or 9%, to $19.2 million in the third quarter of 2003. This decrease is primarily the result of lower shipments of Ogilvie and Woolite, despite market share growth in both products. Our dollar market share for both Ogilvie and Woolite increased 2.1 percentage points to 75.1% and 26.5%, respectively, for the third quarter of 2003. The net sales decrease in Ogilvie was due to a continuation of the decline in the at-home permanent category. The net sales decrease in Woolite was due to a strong comparative quarter in the prior year as a result of the timing of new product introductions. In Gloves, our dollar market share decreased to 27.4% in the third quarter of 2003 versus 28.9% for the same period in 2002. This decline was due to a continuation of competitive activity in the category and higher growth in the disposable glove segment. Our market share is stronger in the reusable glove segment.
International/Corporate Sales DivisionNet sales decreased $2.2 million, or 6%, to $32.6 million in the third quarter of 2003. The decrease was due primarily to lower Tampon net sales particularly to the specialty classes of trade, partially offset by increases in Infant Care and Sun Care net sales.
Consolidated Gross ProfitOur consolidated gross profit decreased $7.5 million, or 9%, to $78.0 million in the third quarter of 2003. As a percent of net sales, gross profit decreased 0.9 percentage points, to 52.0% in the third quarter of 2003. The decrease in gross profit and gross profit as a percent of net sales was due to the decrease in net sales, the mix of products sold and the impact of fixed manufacturing costs on lower production volume.
Consolidated Product ContributionOur consolidated product contribution decreased $8.9 million, or 13%, to $59.9 million in the third quarter of 2003. As a percent of net sales, product contribution decreased 2.7 percentage points to 39.9% in the third quarter of 2003. The decrease in product contribution and product contribution as a percent of net sales was due primarily to lower gross profit and higher overall advertising and sales promotion expenses.
Personal Products DivisionProduct contribution decreased $7.0 million, or 14%, to $42.4 million in the third quarter of 2003. As a percent of net sales, product contribution decreased 3.5 percentage points to 43.0% in the third quarter of 2003. The decrease in product contribution and product contribution as a percent of net sales was due to lower net sales and the mix of products sold, the impact of fixed manufacturing costs on lower production volumes and higher advertising and sales promotion expenses.
Consumer Products DivisionProduct contribution increased $0.3 million, or 10%, to $3.3 million in the third quarter of 2003. As a percent of net sales, product contribution increased 2.8 percentage points to 17.5% in the third quarter of 2003. The increase in product contribution and product contribution as a percent of net sales was due primarily to lower advertising and sales promotion expenses.
International/Corporate Sales DivisionProduct contribution decreased $2.2 million, or 13%, to $14.4 million in the third quarter of 2003. As a percent of net sales, product contribution decreased 3.5 percentage points to 44.1% in the third quarter of 2003. The decrease in product contribution and product contribution as a percent of net sales was due to lower net sales and lower gross profit.
Consolidated Operating EarningsOur consolidated operating earnings decreased $9.1 million, or 32%, to $19.6 million in the third quarter of 2003. The decrease in operating earnings was the result of our lower net sales, gross profit and product contribution, and increased advertising and sales promotion expenses as a percent of net sales.
Consolidated Interest ExpenseOur consolidated interest expense was essentially flat at $14.2 million in the third quarter of 2003 and 2002. Interest expense was impacted by:
21
Consolidated Other ExpensesOur consolidated other expenses decreased $0.1 million to $0.4 million in the third quarter of 2003. The amount charged to other expenses represents the discount offered to the third party on the sale of receivables and the amortization of deferred financing costs associated with the formation of the Receivables Facility (see Note 9 in our unaudited consolidated financial statements).
Consolidated Income TaxesOur consolidated income taxes decreased $3.3 million, or 65%, to $1.8 million in the third quarter of 2003. As a percent of pre-tax earnings, our effective tax rate decreased 0.1 percentage points to 36.6% of earnings before income taxes.
Nine Months Ended September 27, 2003 Compared To
Nine Months Ended September 28, 2002
Consolidated Net SalesOur consolidated net sales decreased $48.9 million, or approximately 9%, to $511.0 million for the nine months ended September 27, 2003.
Personal Products DivisionNet sales decreased $40.6 million, or 13%, to $284.0 million for the nine months ended September 27, 2003.
Net sales of Infant Care products decreased $10.9 million, or 6%, to $161.9 million for the nine months ended September 27, 2003. This decrease was driven by lower net sales in our non-core baby wipes business, slower than expected category growth due, we believe, to economic conditions and continued competitive and promotional activities most notably in Cups, Diaper Genie and Baby Magic Toiletries. Overall, market share across our core Infant Care categories for the nine month period ended September 27, 2003 has been relatively stable. We remain the number one and number two branded products, based on dollar market share, in Infant Feeding and Baby Toiletries, respectively. We continue to focus on the introduction of new products to drive category growth and meet consumer needs. We believe product innovation and modernization is a key driver of long-term success and we are committed, as a leader in the Infant Care segment, to bring better value to consumers. See the discussion of new product introductions in the three month comparative section.
Net sales of Feminine Care products decreased $29.7 million, or 20%, to $122.1 million for the nine months ended September 27, 2003. Our dollar market share in Tampons decreased 3.5 percentage points for the nine months ended September 27, 2003, to 26.9%, from 30.4% in the comparable period of 2002. This decline in our net sales and our dollar market share reflects the impact of extensive competitive spending in the tampon category behind the launch of a new entry in the plastic applicator segment. While our tampon consumption lagged year ago due to this competitive entry, shipments were further impacted this year as a result of our defensive promotional activities in 2002, which resulted in higher retailer inventories. We believe our tampon franchise held up well under the competitive launch environment as our market share has generally stabilized over time and quarter to quarter shipments have improved throughout 2003. We introduced improved products, which reached retail shelves in March 2003. The improvements to our tampon products include: a new deodorant fragrance and an improved soft pearlized plastic applicator, which we expect will enable us to gradually gain back share in the plastic applicator segment. In the third quarter of 2003, we announced the launch of a new flushable tampon, Playtex Beyond. This product is scheduled for
22
shipment in January 2004. See our discussion of this new offering in the three month comparative section. We continue to focus on our core growth strategyconverting pad users to tampons and targeting young teens as they enter the feminine care market.
Consumer Products DivisionNet sales increased $1.0 million, or 1%, to $130.8 million for the nine months ended September 27, 2003.
Net sales of Sun Care products increased $3.6 million, or 5%, to $76.7 million for the nine months ended September 27, 2003. It should be noted that the comparable period in 2002 included a reduction in net sales of $3.3 million to adjust for higher than expected 2001 season returns. Excluding this adjustment, net sales for the nine months ended September 27, 2003 were essentially flat versus the prior year despite a shift in early season Sun Care shipments from the fourth quarter of 2002 to the first quarter of 2003, impacting the nine month comparison as retailers choose to build Sun Care inventory later than in previous seasons. Our dollar market share for the nine months ended September 27, 2003 was 21.9%, down 0.2 percentage points versus the comparable 2002 period. The category has been negatively impacted by unfavorable weather patterns. As a result, we monitored customer shipments throughout the season as part of our initiative to reduce the impact of seasonal returns.
Net sales of Household Products/Personal Grooming declined $2.6 million, or 5%, to $54.1 million for the nine months ended September 27, 2003. This decrease is the result of lower shipments in Ogilvie and Binaca, despite market share gains in each product, as the at-home permanent and breath freshener categories continue to decline. Net sales for our Woolite rug and upholstery products increased over the comparable prior year due to the success of our Woolite Oxy Deep, which was launched in 2002. Our dollar market share for Woolite increased by 5.3 percentage points to 28.5% for the nine months ended September 27, 2003. In Gloves, our dollar market share decreased to 28.0% for the nine months ended September 27, 2003 versus 29.6% for the same period in 2002. This decline was due to a continuation of competitive activities and higher growth in the disposable glove segment of the category. While we offer a disposable glove product, we have a greater market share of the reusable glove segment.
International/Corporate Sales DivisionNet sales decreased $9.3 million, or 9%, to $96.2 million for the nine months ended September 27, 2003. A significant portion of this decrease was due to lower Tampon and Sun Care net sales to the specialty classes of trade.
Consolidated Gross ProfitOur consolidated gross profit decreased $42.4 million, or 14%, to $268.0 million for the nine months ended September 27, 2003. As a percent of net sales, gross profit decreased 3.0 percentage points, to 52.4% for the nine months ended September 27, 2003. The decrease in gross profit and gross profit as a percent of net sales was due to the decrease in net sales, the mix of products sold and the impact of fixed manufacturing costs on lower production volumes.
Consolidated Product ContributionOur consolidated product contribution decreased $50.2 million, or 21%, to $194.0 million for the nine months ended September 27, 2003. As a percent of net sales, product contribution decreased 5.7 percentage points to 38.0% for the nine months ended September 27, 2003. The decrease in product contribution and product contribution as a percent of net sales was due primarily to lower gross profit and higher overall advertising and sales promotion expenses.
Personal Products DivisionProduct contribution decreased $44.7 million, or 29%, to $112.1 million for the nine months ended September 27, 2003. As a percent of net sales, product contribution decreased 8.8 percentage points to 39.5% for the nine months ended September 27, 2003. The decrease in product contribution and product contribution as a percent of net sales was due to lower net sales, the mix of products sold, the impact of fixed manufacturing costs on lower production volumes and higher advertising and sales promotion expenses, primarily to defend our tampon franchise.
23
Consumer Products DivisionProduct contribution increased $1.5 million, or 4%, to $40.2 million for the nine months ended September 27, 2003. As a percent of net sales, product contribution increased 0.9 percentage points to 30.8% for the nine months ended September 27, 2003. The increase in product contribution and product contribution as a percent of net sales was due primarily to lower advertising and sales promotion expenses.
International/Corporate Sales DivisionProduct contribution decreased $7.2 million, or 15%, to $42.1 million for the nine months ended September 27, 2003. As a percent of net sales, product contribution decreased 2.9 percentage points to 43.8% for the nine months ended September 27, 2003. The decrease in product contribution and product contribution as a percent of net sales was due to lower net sales, resulting in lower gross profit, the mix of products sold and increased promotional expenses.
Consolidated Operating EarningsOur consolidated operating earnings decreased $51.6 million, or 42%, to $72.7 million for the nine months ended September 27, 2003. The decrease in operating earnings was the result of our lower gross profit and product contribution, and increased advertising and sales promotion expenses, as discussed. This is compared with the prior year period operating earnings which included a restructuring and asset impairment charge of $7.6 million related to the closure of our Watervliet, New York plastic molding facility (see Note 4 in our unaudited consolidated financial statements).
On October 22, 2003, we announced a plan to reduce our workforce at our Dover, Delaware and Sidney, Ohio manufacturing facilities by approximately 115 employees. The workforce reduction action includes a voluntary earlier retirement program, which will result in an acceleration of certain pension costs and result in other benefit expenses that are expected to be recorded in the fourth quarter of fiscal 2003. While we cannot currently determine the amount of the charge, as a portion of it is dependant on the number of individuals that decide to participate in this early retirement program, we believe the pre-tax charge may be in the $2 to $3 million range. We anticipate that this action, once completed, will result in a pre-tax annual savings of approximately $4 million.
Consolidated Interest ExpenseOur consolidated interest expense decreased $4.5 million, or 10%, to $41.1 million for the nine months ended September 27, 2003. The decrease in interest expense was due to the combined impact of:
Expenses Related to Retirement of DebtOn May 29, 2002, we amended our Credit Facility and issued a new $450.0 million Term C Loan and, together with $21.8 million of cash, we repaid in full our outstanding obligations under our Term A Loan and Term B Loan, which collectively totaled $471.8 million (see Note 8 in our unaudited consolidated financial statements). We recorded a pre-tax extraordinary loss during the second quarter ended June 29, 2002 of $5.9 million associated with the write-off of unamortized deferred financing costs relating to our Term A Loan and Term B
24
Loan. In accordance with SFAS No. 145, we have reclassified the $5.9 million pre-tax loss from extraordinary loss to earnings from continuing operations. In addition, we reduced income tax expense by $2.2 million to reclassify the tax benefit of this transaction in accordance with the new accounting standard.
Consolidated Other ExpensesOur consolidated other expenses decreased $0.6 million, or 30%, to $1.5 million for the nine months ended September 27, 2003. The amount charged to other expenses represents the discount offered to the third party on the sale of receivables and the amortization of deferred financing costs associated with the formation of the Receivables Facility (see Note 9 in our unaudited consolidated financial statements). Since this cost is based, in part, on short term interest rates, it has declined in comparison to the nine months ended September 28, 2002 as interest rates have declined.
Consolidated Income TaxesOur consolidated income taxes increased $1.9 million, or 21.6%, to $11.0 million for the nine months ended September 27, 2003. As a percent of pre-tax earnings, our effective tax rate increased 22.1 percentage points to 36.4% of earnings before income taxes. In the first quarter of 2002, we recorded a tax benefit of $14.3 million due to new regulations issued by the U.S. Treasury on March 7, 2002 (see Note 5 in our unaudited consolidated financial statements). The new regulations permit us to partially utilize a previously disallowed capital loss on the sale of Playtex Beauty Care, Inc., which we sold during fiscal 1999. Excluding the impact of this tax benefit in the first quarter of 2002, our effective tax rate for the nine months ended September 28, 2002 was 36.9%.
Liquidity and Capital Resources
On June 26, 2003, we amended our Credit Facility. This amendment provided for revised and more stringent financial covenants and increased the interest rate margin on our Term C Loan and Revolving Credit Facility. Under the revised terms, pricing for London Inter-Bank Offer Rate ("LIBOR") based loans was increased and a Senior Debt Leverage Ratio, as defined in the amended credit agreement, was added. Additionally, pricing for LIBOR-based loans increased by 125 basis points to LIBOR plus 350 basis points for the Term C Loan and 100 basis points to LIBOR plus 400 basis points for the Revolving Credit Facility. Based on our current outstanding indebtedness, the revised pricing would increase our interest expense by approximately $5.5 million on an annualized basis. The amendment requires that we affirm that we are in compliance with our Senior Debt Leverage Ratio prior to initiating any borrowing requests. Compliance is based on the most recent quarterly compliance certificate filed with the banks as adjusted to reflect proposed new senior debt balances. Based upon our most recent quarterly compliance certificate, our maximum Senior Debt borrowing may not exceed $465.0 million. At September 27, 2003, our Senior Debt was $443.3 million. Additionally, as a result of the June 26, 2003 amendment to the senior indebtedness, we paid amendment fees of approximately $1.6 million. These costs were deferred and are being amortized over the remaining term of our Credit Facility.
On November 13, 2002, we announced our intent to undertake a process to evaluate certain strategic alternatives, including, but not limited to, business combinations, selling the entire company, divesting one or more lines of business, and acquiring strategic lines of business. We cannot assure you that this process will result in a transaction. Also, certain scenarios may require us to seek additional debt or equity financing, in certain situations, in connection with some of the strategic alternatives available to us. As we cannot assure you that such financing will be available to us, our ability to execute certain strategic alternatives may be restricted.
At September 27, 2003, long-term debt (including current portion but excluding obligations due to related party) was $793.3 compared to $827.8 million at December 28, 2002. We redeemed $20.0 million of the 6% Convertible Notes on April 24, 2003 and the remaining $10.0 million was redeemed on September 19, 2003. We made a scheduled principal payment of $2.25 million on our Term C Loan in May of 2003 and another payment of $2.25 million in August of 2003.
As of September 27, 2003, our remaining scheduled principal repayment obligations (excluding amounts due to related party) were:
| $4.5 million in 2004, | | $4.5 million in 2007, | |||
| $4.5 million in 2005, | | $213.8 million in 2008, and | |||
| $4.5 million in 2006, | | $561.5 million thereafter. |
25
At September 27, 2003, the undivided fractional interest sold by Playtex A/R LLC to a third party commercial paper conduit under the Receivables Facility was $19.0 million.
The terms of the Credit Facility require us to meet certain financial tests and also include conditions or restrictions on:
| indebtedness and liens, | | certain dividends and other distributions, | |||
| major acquisitions or mergers, | | the application of excess cash flow, and | |||
| capital expenditures and asset sales, | | prepayment and modification of all indebtedness or equity capitalization. |
At September 27, 2003, our working capital (current assets net of current liabilities) decreased $6.1 million to $108.8 million compared to $114.9 million at December 28, 2002.
Our net cash flows from operations increased $1.1 million, to $59.7 million for the first nine months of 2003 compared to the first nine months of 2002. The increase in net cash flows from operations was primarily due to lower working capital levels offset in part by lower net earnings.
Capital expenditures for equipment and facility improvements were $13.8 million for the first nine months of 2003. These expenditures were used primarily to support new products, upgrade production equipment, invest in new technologies, and improve our facilities. Capital expenditures for 2003 are expected to be in the $18.0 million range.
We intend to fund our operating cash, capital expenditures and debt service requirements through cash flow generated from operations, proceeds from the Receivables Facility, and borrowings under the Revolving Credit Facility through fiscal 2007. However, we do not expect to generate sufficient cash flow from operations to make the 2008 and 2009 scheduled principal payments on the Term C Loan, which collectively total $425.3 million. In addition, we do not expect to generate sufficient cash flow from operations to make the $350.0 million scheduled principal payment on the 93/8% Notes due in fiscal 2011. Accordingly, we will have to refinance our obligations, sell assets or raise equity capital to repay the principal amounts of these obligations. Historically, our cash flows from operations and refinancing activities have enabled us to meet all of our obligations. However, we cannot guarantee that our operating results will continue to be sufficient or that future borrowing facilities will be available for the payment or refinancing of our debt on economically attractive terms.
26
Off-Balance Sheet Arrangements and Other Commitments
On occasion, we enter into certain off-balance sheet arrangements and other commitments with unaffiliated third parties. At September 27, 2003, we had two types of off-balance sheet arrangements.
On May 22, 2001, we entered into the Receivables Facility through a wholly owned, special purpose bankruptcy remote subsidiary of ours, Playtex A/R LLC (see Note 9 in our unaudited consolidated financial statements). In May 2003, the Receivable Facility was extended until November 2003. Through the Receivables Facility, we sell on a continuous basis to Playtex A/R LLC substantially all of our domestic customers' trade invoices that we generate. Playtex A/R LLC sells to a third-party commercial paper conduit (the "Conduit") an undivided fractional ownership interest in these trade accounts receivable. We believe the Receivables Facility is beneficial to us as: (1) we convert trade receivables to cash faster, and (2) although we sell our invoices to Playtex A/R LLC at a discount and pay fees to the Conduit, these expenses are lower than our borrowing costs under the Credit Facility. We sold $19.0 million of undivided fractional interest in our receivables at September 27, 2003, and $39.0 million of undivided fractional interest in our receivables at December 28, 2002, to the Conduit.
We also enter into operating leases with unaffiliated third parties. These leases are primarily for buildings, manufacturing equipment, automobiles and information technology equipment. At September 27, 2003 and December 28, 2002, we had in aggregate approximately $27.7 million and $32.0 million of committed expenses, respectively, associated with operating leases that are not reflected on our Consolidated Balance Sheets as a liability, in accordance with generally accepted accounting principles. We believe operating leases are beneficial as they allow us to better match cash flows associated with the asset and the benefits derived from it. Operating leases also provide us with greater flexibility in regards to technological change, minimizing the risk of our productive assets becoming obsolete.
Critical Accounting Policies
The preparation of financial statements in accordance with generally accepted accounting principles requires us to make estimates and assumptions. These estimates and assumptions affect:
Actual results could vary from our estimates and assumptions. These estimates and assumptions are based on historical results, assumptions that we make, as well as assumptions by third parties.
The level of reserves for Sun Care product returns, bad debts and advertising and promotional costs are three areas of which you should be aware.
27
Recently Issued Accounting Standards
In April 2002, the FASB issued SFAS No. 145, "Rescission of FASB Statements No. 4, 44, and 64, Amendment of FASB Statement No. 13, and Technical Corrections." This statement updates, clarifies and simplifies existing accounting pronouncements and became effective for us starting in fiscal 2003. In most instances, SFAS No. 145 will require gains and losses on extinguishments of debt to be classified as income or loss from continuing operations rather than as extraordinary items as previously required under the old accounting rules. Starting in 2003, any gain or loss on extinguishment of debt, previously classified as an extraordinary item in prior periods presented, that does not meet the criteria of APB No. 30 for such classification, will be reclassified to conform to the provisions of SFAS No. 145. In accordance with SFAS No. 145, we have reclassified the May 2002 $5.9 million pre-tax extraordinary loss to earnings from continuing operations. In addition, we reduced income tax expense by $2.2 million to reclassify the tax benefit of this transaction in accordance with the new accounting standard.
In July 2002, the FASB issued SFAS No. 146, "Accounting for Costs Associated with Exit or Disposal Activities" and nullified EITF Issue No. 94-3. SFAS No. 146 requires that a liability for a cost associated with an exit or disposal activity be recognized when the liability is incurred, whereas EITF No. 94-3 had recognized the liability at the commitment date to an exit plan. We are required to apply the provisions of SFAS No. 146 effective for exit or disposal activities initiated after December 28, 2002.
In December 2002, the FASB issued SFAS No. 148, "Accounting for Stock-Based CompensationTransition and Disclosure." SFAS No. 148 provides alternative methods of transition for a voluntary change to the fair value method of accounting for stock-based employee compensation as originally provided by SFAS No. 123. Additionally, SFAS No. 148 amends the disclosure requirements of SFAS No. 123 to require prominent disclosure in both the annual and interim financial statements about the method of accounting for stock-based compensation and the effect of the method used on reported results (see Note 2 in our unaudited consolidated financial statements). The transitional requirements of SFAS No. 148 are effective for all financial statements for fiscal years ending after December 15, 2002. We adopted the disclosure portion of this statement beginning in the first quarter 2003. The application of the disclosure portion of this standard will have no impact on our consolidated financial position or results of operations. The FASB recently indicated that they will likely require stock-based employee compensation to be recorded as a charge to earnings pursuant to a standard they are currently deliberating, which they believe will become effective on January 1, 2004. We will continue to monitor their progress on the issuance of this standard and the impact it may have on our consolidated financial statements.
Effective June 29, 2003, we adopted SFAS No. 149, "Amendment of Statement 133 on Derivative Instruments and Hedging Activities." This statement amends and clarifies financial accounting and reporting for derivatives and for hedging activities under SFAS No. 133, "Accounting for Derivative Instruments and Hedging Activities." This standard has no impact on our consolidated financial statements.
28
In May 2003, the FASB issued SFAS No. 150, "Accounting for Certain Financial Instruments with Characteristics of both Liabilities and Equity." This standard requires that certain financial instruments embodying an obligation to transfer assets to issue equity securities be classified as liabilities. It is effective for financial instruments entered into or modified after May 31, 2003, and otherwise is effective July 1, 2003. This standard has no impact on our consolidated financial statements.
In January 2003, the FASB issued Interpretation No. 46, ("FIN 46") "Consolidation of Variable Interest Entities." FIN 46 requires a company to consolidate a variable interest entity (VIE), as defined, when the company will absorb a majority of the VIE's expected losses, receive a majority of the VIE's expected residual returns, or both. FIN 46 also requires consolidation of existing, non-controlled affiliates if the VIE is unable to finance its operations without investor support, or where the other investors do not have exposure to the significant risks and rewards of ownership. FIN 46 applies immediately to a VIE created or acquired after January 31, 2003. For a VIE created before February 1, 2003, FIN 46 applies in the first fiscal year or interim period beginning after December 15, 2003. This interpretation has no impact on our consolidated financial statements.
29
PLAYTEX PRODUCTS, INC.
PART 1FINANCIAL INFORMATION
QUANTITATIVE AND QUALITATIVE DISCLOSURE ABOUT MARKET RISK
Item 3. Quantitative and Qualitative Disclosure about Market Risk
We periodically use financial instruments, such as derivatives, to manage the impact of interest rate changes on our variable rate debt and its effect on our earnings and cash flows. Our policies prohibit the use of derivative instruments for the sole purpose of trading for profit on price fluctuations or to enter into contracts, which intentionally increase our underlying interest rate exposure. At September 27, 2003, we were not a party to any financial instruments and our total indebtedness consisted of $350.0 million in fixed rate debt and $443.3 million in variable rate debt. Based on our interest rate exposure at September 27, 2003, a 1% increase in interest rates for our variable rate debt would result in an estimated $4.4 million of additional interest expense on an annualized basis.
Item 4. Controls and Procedures
It should be noted that any system of controls, however well designed and operated, can provide only reasonable, and not absolute, assurance that the objectives of the system will be met. In addition, the design of any control system is based in part upon certain assumptions about the likelihood of future events. Because of these and other inherent limitations of control systems, there is only reasonable assurance that our controls will succeed in achieving their stated goals under all potential future conditions.
30
The following should be read in conjunction with Part 1, Item 3., "Legal Proceedings" in our Annual Report on Form 10-K for the year ended December 28, 2002.
As of the end of October 2003, there were 6 pending toxic shock syndrome claims relating to Playtex tampons, although additional claims may be made in the future.
Item 6. Exhibits and Reports on Form 8-K
On July 24, 2003, we furnished a current report on Form 8-K with the Securities and Exchange Commission pursuant to Items 7, 9, and 12 of that Form. Pursuant to Items 7, 9, and 12, we provided information on earnings results for the second quarter of 2003.
31
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
PLAYTEX PRODUCTS, INC. | |||
Date: November 10, 2003 | By: | /s/ MICHAEL R. GALLAGHER Michael R. Gallagher Chief Executive Officer (Principal Executive Officer) |
|
Date: November 10, 2003 | By: | /s/ GLENN A. FORBES Glenn A. Forbes Executive Vice President and Chief Financial Officer (Principal Financial and Accounting Officer) |
32